U.S. flag

An official website of the United States government

NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu) AND not provided

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Jun 13, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000212152.13

Allele description [Variation Report for NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)]

NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)

Gene:
BRAF:B-Raf proto-oncogene, serine/threonine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q34
Genomic location:
Preferred name:
NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)
Other names:
p.G469E:GGA>GAA; NM_004333.5(BRAF):c.1406G>A; NM_004333.6(BRAF):c.1406G>A
HGVS:
  • NC_000007.14:g.140781602C>T
  • NG_007873.3:g.148163G>A
  • NM_001354609.2:c.1406G>A
  • NM_001374244.1:c.1526G>A
  • NM_001374258.1:c.1526G>A
  • NM_001378467.1:c.1415G>A
  • NM_001378468.1:c.1406G>A
  • NM_001378469.1:c.1340G>A
  • NM_001378470.1:c.1304G>A
  • NM_001378471.1:c.1295G>A
  • NM_001378472.1:c.1250G>A
  • NM_001378473.1:c.1250G>A
  • NM_001378474.1:c.1406G>A
  • NM_001378475.1:c.1142G>A
  • NM_004333.6:c.1406G>AMANE SELECT
  • NP_001341538.1:p.Gly469Glu
  • NP_001361173.1:p.Gly509Glu
  • NP_001361187.1:p.Gly509Glu
  • NP_001365396.1:p.Gly472Glu
  • NP_001365397.1:p.Gly469Glu
  • NP_001365398.1:p.Gly447Glu
  • NP_001365399.1:p.Gly435Glu
  • NP_001365400.1:p.Gly432Glu
  • NP_001365401.1:p.Gly417Glu
  • NP_001365402.1:p.Gly417Glu
  • NP_001365403.1:p.Gly469Glu
  • NP_001365404.1:p.Gly381Glu
  • NP_004324.2:p.Gly469Glu
  • LRG_299t1:c.1406G>A
  • LRG_299:g.148163G>A
  • NC_000007.13:g.140481402C>T
  • NM_001374258.1:c.1526G>A
  • NM_004333.4:c.1406G>A
  • NM_004333.5:c.1406G>A
  • P15056:p.Gly469Glu
  • c.1406G>A
Protein change:
G381E; GLY469GLU
Links:
UniProtKB: P15056#VAR_018621; OMIM: 164757.0014; dbSNP: rs121913355
NCBI 1000 Genomes Browser:
rs121913355
Molecular consequence:
  • NM_001354609.2:c.1406G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374244.1:c.1526G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374258.1:c.1526G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378467.1:c.1415G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378468.1:c.1406G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378469.1:c.1340G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378470.1:c.1304G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378471.1:c.1295G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378472.1:c.1250G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378473.1:c.1250G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378474.1:c.1406G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378475.1:c.1142G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004333.6:c.1406G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000057212GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Jun 13, 2022)
germlineclinical testing

Citation Link,

SCV000225337Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Pathogenic
(Jul 27, 2014)
germlineclinical testing

Citation Link,

SCV001714860Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jun 23, 2020)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown2not providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.

Schulz AL, Albrecht B, Arici C, van der Burgt I, Buske A, Gillessen-Kaesbach G, Heller R, Horn D, Hübner CA, Korenke GC, König R, Kress W, Krüger G, Meinecke P, Mücke J, Plecko B, Rossier E, Schinzel A, Schulze A, Seemanova E, Seidel H, Spranger S, et al.

Clin Genet. 2008 Jan;73(1):62-70. Epub 2007 Nov 27.

PubMed [citation]
PMID:
18042262

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.

Niihori T, Aoki Y, Narumi Y, Neri G, Cavé H, Verloes A, Okamoto N, Hennekam RC, Gillessen-Kaesbach G, Wieczorek D, Kavamura MI, Kurosawa K, Ohashi H, Wilson L, Heron D, Bonneau D, Corona G, Kaname T, Naritomi K, Baumann C, Matsumoto N, Kato K, et al.

Nat Genet. 2006 Mar;38(3):294-6. Epub 2006 Feb 12.

PubMed [citation]
PMID:
16474404
See all PubMed Citations (4)

Details of each submission

From GeneDx, SCV000057212.16

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Published functional studies demonstrate a damaging effect on B-Raf activity and MEK and ERK phosphorylation (Rodriguez-Viciana et al., 2006); Missense variants in this gene are often considered pathogenic (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23093928, 34573299, 30141192, 34184824, 29907801, 18042262, 16474404, 16439621, 19206169, 24803665, 33040082)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Eurofins Ntd Llc (ga), SCV000225337.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV001714860.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (4)

Description

PP2, PP3, PM1, PM2, PS2_VeryStrong, PS3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 3, 2024